Imatinib in pregnancy

被引：42

作者：

AlKindi, S ^{[1
]}

Dennison, D ^{[1
]}

Pathare, A ^{[1
]}

机构：

[1] Sultan Qaboos Univ Hosp, Muscat, Oman

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2005年 / 74卷 / 06期

关键词：

D O I：

10.1111/j.1600-0609.2005.00420.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：535 / 537

页数：3

共 8 条

[1] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[2] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].

Druker, BJ ;

Lydon, NB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7

[3] Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib [J].

Heartin, E ;

Walkinshaw, S ;

Clark, RE .

LEUKEMIA & LYMPHOMA, 2004, 45 (06) :1307-1308

[4] Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].

Heinrich, MC ;

Griffith, DJ ;

Druker, BJ ;

Wait, CL ;

Ott, KA ;

Zigler, AJ .

BLOOD, 2000, 96 (03) :925-932

[5] Imatinib treatment: Specific issues related to safety, fertility, and pregnancy [J].

Hensley, ML ;

Ford, JM .

SEMINARS IN HEMATOLOGY, 2003, 40 (02) :21-25

[6] Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia [J].

Kabarowski, JHS ;

Witte, ON .

STEM CELLS, 2000, 18 (06) :399-408

[7] The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [J].

Melo, JV .

BLOOD, 1996, 88 (07) :2375-2384

[8] Chronic myeloid leukemia [J].

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1330-1340

← 1 →